{"created":"2023-06-20T15:47:24.261674+00:00","id":1940,"links":{},"metadata":{"_buckets":{"deposit":"bc181246-0016-4b98-af93-38336fce4c6f"},"_deposit":{"created_by":4,"id":"1940","owners":[4],"pid":{"revision_id":0,"type":"depid","value":"1940"},"status":"published"},"_oai":{"id":"oai:hama-med.repo.nii.ac.jp:00001940","sets":["1:11"]},"author_link":["4932"],"item_3_biblio_info_5":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"1989-05-01","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"5","bibliographicPageEnd":"589","bibliographicPageStart":"585","bibliographicVolumeNumber":"41","bibliographic_titles":[{"bibliographic_title":"日本産科婦人科學會雜誌","bibliographic_titleLang":"ja"}]}]},"item_3_description_9":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"婦人科疾患, とくに卵巣癌におけるCA72-4の臨床的有用性をCA125との比較により検討した。血清CA72-4値の正常上限を3.9 U/mlとすると, 健常非妊婦, 子宮筋腫患者はすべて陰性を示した。子宮腺筋症7例中2例, 良性卵巣腫瘍45例中3例が偽陽性を示したが, CA125よりかなり低い偽陽性率であった。卵巣癌I, II, IIIおよびIV期における陽性率はそれぞれ8.3, 25.0, 48.0および85.7%と臨床進行期が進むにつれて陽性率も高値を示した。組織型別陽性率は漿液性嚢胞腺癌39.1%, ムチン性嚢胞腺癌52.0%, 類内膜癌44.4%, および類中腎癌33.3%を示し, CA125と異なり, ムチン性嚢胞腺癌で高値を示した。なお, CA125との同時測定を行ってもオーバーラップは認められず, 両者は独立した腫瘍マーカーであると推定される。以上よりCA72-4は良性疾患における偽陽性率が低くムチン性嚢胞腺癌で高い陽性率を示し, CA125の欠点を補い得る有用な腫瘍マーカーであることが証明された","subitem_description_language":"ja","subitem_description_type":"Abstract"}]},"item_3_publisher_6":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"日本産科婦人科学会","subitem_publisher_language":"ja"}]},"item_3_rights_7":{"attribute_name":"権利","attribute_value_mlt":[{"subitem_rights":"Copyright 日本産科婦人科学会","subitem_rights_language":"ja"},{"subitem_rights":"本文データは学協会の許諾に基づきCiNiiから複製したものである","subitem_rights_language":"ja"}]},"item_3_source_id_19":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"03009165","subitem_source_identifier_type":"ISSN"}]},"item_3_version_type_32":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"小林, 浩","creatorNameLang":"ja"}],"nameIdentifiers":[{"nameIdentifier":"4932","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2018-08-27"}],"displaytype":"detail","filename":"sankafujinka-41_5-585.pdf","filesize":[{"value":"494.5 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"sankafujinka-41_5-585.pdf","url":"https://hama-med.repo.nii.ac.jp/record/1940/files/sankafujinka-41_5-585.pdf"},"version_id":"4c8e6c57-2da8-4e74-ac5d-cbb044bdc363"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"CA72-4","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"CA125","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Ovarian cancer","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Tumor marker","subitem_subject_language":"en","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"婦人科疾患, とくに卵巣癌におけるCA72-4の臨床的有用性","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"婦人科疾患, とくに卵巣癌におけるCA72-4の臨床的有用性","subitem_title_language":"ja"}]},"item_type_id":"3","owner":"4","path":["11"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2013-08-27"},"publish_date":"2013-08-27","publish_status":"0","recid":"1940","relation_version_is_last":true,"title":["婦人科疾患, とくに卵巣癌におけるCA72-4の臨床的有用性"],"weko_creator_id":"4","weko_shared_id":-1},"updated":"2023-08-02T07:20:09.855700+00:00"}